title: Analysis of von Willebrand factor mRNA from the lung of pigs with severe von Willebrand disease by using a human cDNA probe.
abstract: To examine the control of porcine von Willebrand factor (vWF) biosynthesis we cloned human vWF complementary DNA (cDNA) and investigated the expression of the vWF gene in lungs from normal pigs and pigs with severe von Willebrand's disease (vWD). Recombinant clones spanning approximately 90% of human vWF cDNA were identified in a lambda gt10 human lung cDNA library by screening with oligonucleotides. One clone spanning nucleotides 960 to 3,240 of human vWF cDNA was used to investigate the steady-state levels of vWF mRNA in lungs from normal pigs and from pigs phenotypically determined to be homozygous for vWD. This clone hybridized with genomic DNA from pig leukocytes when Southern blots were processed under very stringent conditions; therefore, human cDNA clones were considered valid probes to detect porcine mRNA. Northern blot analysis of total RNA from normal pig lung and human umbilical vein endothelial cells identified the vWF mRNA as a molecular species of approximately 9.0 kilobases (kb). A very faint to undetectable band at 9.0 kb in total RNA from lungs of vWD pigs suggested a decreased rate of transcription of the vWF gene. Sucrose density gradient centrifugation of RNA from the vWD pigs confirmed by Northern analysis that the high-molecular weight fractions contained vWF mRNA and at the same size as normal pig mRNA. Dot blot hybridization analysis of vWF and actin mRNA processed under stringent conditions demonstrated that the relative ratio of vWF mRNA to actin mRNA in the vWD pigs varied from 21% to 41% of the ratio observed in normal pigs. Because the amount of vWF mRNA is not correlated to the amount of vWF activity or antigen in plasma of vWD pigs we conclude that posttranscriptional events are also probably involved in abnormal expression of vWF in these animals.
authors.affiliation: Institut National de la Sante et de la Recherche Médicale (INSERM) U.143, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
authors.forename: Q Y
authors.initials: QY
authors.lastname: Wu
authors.forename: B R
authors.initials: BR
authors.lastname: Bahnak
authors.forename: L
authors.initials: L
authors.lastname: Coulombel
authors.forename: D
authors.initials: D
authors.lastname: Kerbiriou-Nabias
authors.forename: L
authors.initials: L
authors.lastname: Drouet
authors.forename: G
authors.initials: G
authors.lastname: Piétu
authors.forename: P
authors.initials: P
authors.lastname: Meulien
authors.forename: A
authors.initials: A
authors.lastname: Pavirani
authors.forename: J P
authors.initials: JP
authors.lastname: Caen
authors.forename: D
authors.initials: D
authors.lastname: Meyer
mesh_terms: D000818:Animals; D004247:DNA / Q000235:genetics; D004274:DNA, Recombinant; D004195:Disease Models, Animal; D005786:Gene Expression Regulation; D006801:Humans; D008168:Lung / Q000032:analysis*; D012323:RNA Processing, Post-Transcriptional; D012333:RNA, Messenger / Q000032:analysis*; D013552:Swine / Q000235:genetics* / Q000378:metabolism; D014842:von Willebrand Diseases / Q000235:genetics* / Q000378:metabolism; D014841:von Willebrand Factor / Q000235:genetics*
chemical_list: D004274:DNA, Recombinant; D012333:RNA, Messenger; D014841:von Willebrand Factor; D004247:DNA